Glucocorticoids antagonize estrogens by glucocorticoid receptor-mediated activation of estrogen sulfotransferase

Cancer Research

Volumn 68, Issue 18, 2008, Pages 7386-7393

  Gong, Haibiao ^a   Jarzynka, Michael J ^b   Cole, Timothy J ^d   Jung, Hoon Lee ^a   Wada, Taira ^a   Zhang, Bin ^a   Gao, Jie ^a   Song, Wen Chao ^e   DeFranco, Donald B ^c   Cheng, Shi Yuan ^b   Xie, Wen ^a,c  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d MONASH UNIVERSITY   (Australia)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL NUCLEUS RECEPTOR; DEXAMETHASONE; ESTRADIOL; ESTROGEN SULFOTRANSFERASE; GLUCOCORTICOID RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER; CANCER GROWTH; CONTROLLED STUDY; ENZYME ACTIVITY; ESTROGEN RESPONSIVE ELEMENT; FEMALE; GENE DELETION; GENE EXPRESSION; IN VITRO STUDY; MOUSE; NONHUMAN; NORTHERN BLOTTING; OVARIECTOMY; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK FACTOR; XENOGRAFT;

ANIMALS; BREAST NEOPLASMS; CELL GROWTH PROCESSES; CELL LINE, TUMOR; DEXAMETHASONE; ENZYME ACTIVATION; ESTRADIOL; ESTROGEN ANTAGONISTS; ESTROGENS; FEMALE; HUMANS; LIVER; MICE; MICE, INBRED C57BL; MICE, NUDE; NEOPLASMS, HORMONE-DEPENDENT; RECEPTORS, GLUCOCORTICOID; RNA, MESSENGER; SULFOTRANSFERASES; TRANSCRIPTION, GENETIC; UTERUS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 54749155579     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-08-1545     Document Type: Article

References (55)

1. Rosen J, Miner JN. The search for safer glucocorticoid receptor ligands. Endocr Rev 2005;26:452-64.
2. Zhou J, Cidlowski JA. The human glucocorticoid receptor: one gene, multiple proteins and diverse responses. Steroids 2005;70:407-17.
3. Yudt MR, Cidlowski JA. The glucocorticoid receptor: coding a diversity of proteins and responses through a single gene. Mol Endocrinol 2002;16:1719-26.
4. Dahlman-Wright K, Siltala-Roos H, Carlstedt-Duke J, Gustafsson JA. Protein-protein interactions facilitate DNA binding by the glucocorticoid receptor DNA-binding domain. J Biol Chem 1990;265:14030-5.
5. Oakley RH, Webster JC, Jewell CM, Sar M, Cidlowski JA. Immunocytochemical analysis of the glucocorticoid receptor α isoform (GRα) using GRα-specific antibody. Steroids 1999;64:742-51.
6. Wang JC, Derynck MK, Nonaka DF, Khodabakhsh DB, Haqq C, Yamamoto KR. Chromatin immunoprecipitation (ChIP) scanning identifies primary glucocorticoid receptor target genes. Proc Natl Acad Sci U S A 2004; 101:15603-8.
7. Hewitt SC, Harrell JC, Korach KS. Lessons in estrogen biology from knockout and transgenic animals. Annu Rev Physiol 2005;67:285-308.
8. Simpson ER, Misso M, Hewitt KN, et al. Estrogen-the good, the bad, and the unexpected. Endocr Rev 2005;26:322-30.
9. Hewitt SC, Deroo BJ, Hansen K, et al. Estrogen receptor-dependent genomic responses in the uterus mirror the biphasic physiological response to estrogen. Mol Endocrinol 2003;17:2070-83.
10. Jensen EV. From chemical warfare to breast cancer management. Nat Med 2004;10:1018-21.
11. Yager JD, Davidson NE. Estrogen carcinogenesis in breast cancer. N Engl J Med 2006;354:270-82.
12. O'Malley BW. A life-long search for the molecular pathways of steroid hormone action. Mol Endocrinol 2005;19:1402-11.
13. Jordan VC, Morrow M. Tamoxifen, raloxifene, and the prevention of breast cancer. Endocr Rev 1999;20:253-78.
14. Pasqualini JR. The selective estrogen enzyme modulators in breast cancer: a review. Biochim Biophys Acta 2004;1654:123-43.
15. Song WC. Biochemistry and reproductive endocrinology of estrogen sulfotransferase. Ann N Y Acad Sci 2001;948:43-50.
16. Zhang H, Varlamova O, Vargas FM, Falany CN, Leyh TS. Sulfuryl transfer: the catalytic mechanism of human estrogen sulfotransferase. J Biol Chem 1998;273:10888-92.
17. Kakuta Y, Pedersen LC, Chae K, et al. Mouse steroid sulfotransferases: substrate specificity and preliminary X-ray crystallographic analysis. Biochem Pharmacol 1998;55:313-7.
18. Tong MH, Jiang H, Liu P, Lawson JA, Brass LF, Song WC. Spontaneous fetal loss caused by placental thrombosis in estrogen sulfotransferase-deficient mice. Nat Med 2005;11:153-9.
19. Falany JL, Macrina N, Falany CN. Regulation of MCF-7 breast cancer cell growth by β-estradiol sulfation. Breast Cancer Res Treat 2002;74:167-76.
20. Qian Y, Deng C, Song WC. Expression of estrogen sulfotransferase in MCF-7 cells by cDNA transfection suppresses the estrogen response: potential role of the enzyme in regulating estrogen-dependent growth of breast epithelial cells. J Pharmacol Exp Ther 1998;286:555-60.
21. Falany JL, Falany CN. Regulation of estrogen activity by sulfation in human MCF-7 breast cancer cells. Oncol Res 1997;9:589-96.
22. Bever AT, Hisaw FL, Velardo JT. Inhibitory action of desoxycorticosterone acetate, cortisone acetate, and testosterone on uterine growth induced by estradiol-17β. Endocrinology 1956;59:165-9.
23. Campbell PS. The mechanism of the inhibition of uterotrophic responses by acute dexamethasone pretreatment. Endocrinology 1978;103:716-23.
24. Rhen T, Grissom S, Afshari C, Cidlowski JA. Dexamethasone blocks the rapid biological effects of 17β-estradiol in the rat uterus without antagonizing its global genomic actions. FASEB J 2003;17:1849-70.
25. Sahlin L. Dexamethasone attenuates the estradiol-induced increase of IGF-I mRNA in the rat uterus. J Steroid Biochem Mol Biol 1995;55:9-15.
26. Zhou F, Bouillard B, Pharaboz-Joly MO, Andre J. Non-classical antiestrogenic actions of dexamethasone in variant MCF-7 human breast cancer cells in culture. Mol Cell Endocrinol 1989;66:189-97.
27. Cole TJ, Blendy JA, Monaghan AP, et al. Targeted disruption of the glucocorticoid receptor gene blocks adrenergic chromaffin cell development and severely retards lung maturation. Genes Dev 1995;9:1608-21.
28. Qian YM, Sun XJ, Tong MH, Li XP, Richa J, Song WC. Targeted disruption of the mouse estrogen sulfotransferase gene reveals a role of estrogen metabolism in intracrine and paracrine estrogen regulation. Endocrinology 2001;142:5342-50.
29. Xie W, Barwick JL, Downes M, et al. Humanized xenobiotic response in mice expressing nuclear receptor SXR. Nature 2000;406:435-9.
30. Gong H, Guo P, Zhai Y, et al. Estrogen deprivation and inhibition of breast cancer growth in vivo through activation of the orphan nuclear receptor liver X receptor. Mol Endocrinol 2007;21:1781-90.
31. Gong H, Singh SV, Singh SP, et al. Orphan nuclear receptor pregnane X receptor sensitizes oxidative stress responses in transgenic mice and cancerous cells. Mol Endocrinol 2006;20:279-90.
32. Strom SC, Pisarov LA, Dorko K, Thompson MT, Schuetz JD, Schuetz EG. Use of human hepatocytes to study P450 gene induction. Methods Enzymol 1996;272:388-401.
33. Mu Y, Stephenson CR, Kendall C, et al. A pregnane X receptor agonist with unique species-dependent stereoselectivity and its implications in drug development. Mol Pharmacol 2005;68:403-13.
34. Wada T, Kang HS, Angers M, et al. Identification of oxysterol 7α-hydroxylase (Cyp7b1) as a novel retinoid-related orphan receptor α (RORα) (NR1F1) target gene and a functional cross-talk between RORα and liver X receptor (NR1H3). Mol Pharmacol 2008;73:891-9.
35. Blumberg B, Sabbagh W, Jr., Juguilon H, et al. SXR, a novel steroid and xenobiotic-sensing nuclear receptor. Genes Dev 1998;12:3195-205.
36. Bookout AL, Jeong Y, Downes M, Yu RT, Evans RM, Mangelsdorf DJ. Anatomical profiling of nuclear receptor expression reveals a hierarchical transcriptional network. Cell 2006;126:789-99.
37. Das SK, Tan J, Johnson DC, Dey SK. Differential spatiotemporal regulation of lactoferrin and progesterone receptor genes in the mouse uterus by primary estrogen, catechol estrogen, and xenoestrogen. Endocrinology 1998;139:2905-15.
38. Deroo BJ, Hewitt SC, Peddada SD, Korach KS. Estradiol regulates the thioredoxin antioxidant system in the mouse uterus. Endocrinology 2004;145:5485-92.
39. Klotz DM, Hewitt SC, Ciana P, et al. Requirement of estrogen receptor-α in insulin-like growth factor-1 (IGF-1)-induced uterine responses and in vivo evidence for IGF-1/estrogen receptor cross-talk. J Biol Chem 2002;277:8531-7.
40. Mendoza-Rodriguez CA, Camacho-Arroyo I, Garcia GA, Cerbon MA. Variations of progesterone receptor and c-fos gene expression in the rat uterus after treatment with norethisterone and its A-ring reduced metabolites. Contraception 1999;59:339-43.
41. Guo P, Fang Q, Tao HQ, et al. Overexpression of vascular endothelial growth factor by MCF-7 breast cancer cells promotes estrogen-independent tumor growth in vivo. Cancer Res 2003;63:4684-91.
42. Tsuchiya Y, Nakajima M, Yokoi T. Cytochrome P450-mediated metabolism of estrogens and its regulation in human. Cancer Lett 2005;227:115-24.
43. Heuman DM, Gallagher EJ, Barwick JL, Elshourbagy NA, Guzelian PS. Immunochemical evidence for induction of a common form of hepatic cytochrome P-450 in rats treated with pregnenolone-16 α-carbonitrile or other steroidal or non-steroidal agents. Mol Pharmacol 1982;21:753-60.
44. Bitman J, Cecil HC. Differential inhibition by cortisol of estrogen-stimulated uterine responses. Endocrinology 1967;80:423-9.
45. Tontonoz P, Mangelsdorf DJ. Liver X receptor signaling pathways in cardiovascular disease. Mol Endocrinol 2003;17:985-93.
46. Chiang JY, Kimmel R, Stroup D. Regulation of cholesterol 7α-hydroxylase gene (CYP7A1) transcription by the liver orphan receptor (LXRα). Gene 2001;262:257-65.
47. Leiter EH, Chapman HD. Obesity-induced diabetes (diabesity) in C57BL/KsJ mice produces aberrant transregulation of sex steroid sulfotransferase genes. J Clin Invest 1994;93:2007-13.
48. Gill AM, Leiter EH, Powell JG, Chapman HD, Yen TT. Dexamethasone-induced hyperglycemia in obese Avy/a (viable yellow) female mice entails preferential induction of a hepatic estrogen sulfotransferase. Diabetes 1994;43:999-1004.
49. Alnouti Y, Klaassen CD. Regulation of sulfotransferase enzymes by prototypical microsomal enzyme inducers in mice. J Pharmacol Exp Ther 2008;324:612-21.
50. Suzuki T, Nakata T, Miki Y, et al. Estrogen sulfotransferase and steroid sulfatase in human breast carcinoma. Cancer Res 2003;63:2762-70.
51. Bernal-Mizrachi C, Weng S, Feng C, et al. Dexamethasone induction of hypertension and diabetes is PPAR-α dependent in LDL receptor-null mice. Nat Med 2003;9:1069-75.
52. Liu L, Klaassen CD. Regulation of hepatic sulfotransferases by steroidal chemicals in rats. Drug Metab Dispos 1996;24:854-8.
53. Runge-Morris M, Rose K, Kocarek TA. Regulation of rat hepatic sulfotransferase gene expression by glucocorticoid hormones. Drug Metab Dispos 1996;24:1095-101.
54. Duanmu Z, Locke D, Smigelski J, et al. Effects of dexamethasone on aryl (SULT1A1)- and hydroxysteroid (SULT2A1)-sulfotransferase gene expression in primary cultured human hepatocytes. Drug Metab Dispos 2002;30:997-1004.
55. Warren MP. A comparative review of the risks and benefits of hormone replacement therapy regimens. Am J Obstet Gynecol 2004;190:1141-67.